Table 3 Imaging marker progression
| Â | Low risk at baseline | High risk at baseline | Â | |||
|---|---|---|---|---|---|---|
| Â | No progression (%) | With progression (%) | With regression (%) | With progression (%) | No progression (%) | Total number with progression (%) |
CAC (n = 142) | 103 (72.5) | 12 (8.5) | 2 (1.4) | 21 (14.8) | 4 (2.8) | 33 (23.2) |
AS (n = 106) | 67 (63.2) | 12 (11.3) | 4 (3.8) | 23 (21.7) | 0 | 35 (33.0) |